中国实用儿科杂志
• 专题笔谈 • 上一篇 下一篇
出版日期:
发布日期:
Online:
Published:
摘要:
胸腔积液通常是一些疾病进展过程中的并发症,常见疾病包括心衰、感染、恶性肿瘤等。恶性胸腔积液(malignant pleural effusions,MPEs)是由恶性肿瘤引起的胸腔积液。目前对MPEs的了解,包括其诊断、治疗方面已经取得了巨大进步。特异性分子标记物检测、危险度分级及胸腔导管介入术逐步发展,并可能在未来成为诊疗标准。MPEs诊治方法的进步给临床工作带来了新的希望。
关键词: 胸腔积液, 恶性肿瘤, 诊断, 治疗
Abstract:
Pleural effusions usually arise as underlying disease processes,including heart failure,infection, malignancy,etc. Malignant pleural effusions(MPEs)are caused by malignant tumors. Our understanding of MPEs,including diagnosis and treatment,has made tremendous progress. Specific molecular marker detection,risk stratification,and thoracic catheterization may develop progressively and may become the standard of care in the future. Progress in the diagnosis and treatment of malignant pleural effusion has brought new hope to the clinical work.
Key words: pleural effusion, malignant tumor, diagnosis, treatment
张冰玉,金润铭. 恶性胸腔积液诊断及治疗[J]. 中国实用儿科杂志, DOI: 10.19538/j.ek2017030606.
ZHANG Bing-yu,JIN Run-ming. Diagnosis and treatment of malignant pleural effusion[J]. CJPP, DOI: 10.19538/j.ek2017030606.
0 / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.zgsyz.com/zgsyek/CN/10.19538/j.ek2017030606
https://www.zgsyz.com/zgsyek/CN/Y2017/V32/I3/178